Spectrum Brands Holdings, Inc. quarterly report, Q2 FY2024

Business Context and Reporting Period

Spectrum Brands Holdings, Inc. and SB/RH Holdings, LLC filed a combined unaudited Form 10-Q for the three and six months ended March 31, 2024, compared with periods ended April 2, 2023. The continuing business comprises Global Pet Care (GPC), Home & Garden (H&G), and Home & Personal Care (HPC). The Hardware and Home Improvement (HHI) segment was divested on June 20, 2023 and is presented as discontinued operations.

Key Financial Metrics

MetricThree Months Ended March 31, 2024Six Months Ended March 31, 2024Comparable Change
Net sales$718.5 million$1,410.7 millionDown 1.5% and 2.2%
Gross profit$273.4 million$518.4 millionUp 27.5% and 24.5%
Gross margin38.1%36.7%Up 870 and 780 basis points
Operating income$75.9 million$101.0 millionPrior-year losses of $77.0 million and $97.2 million
Net income from continuing operations$49.9 million$67.4 millionPrior-year losses of $75.0 million and $115.0 million
Net income attributable to controlling interest$61.1 million$90.2 millionPrior-year losses of $53.7 million and $74.6 million
Diluted EPS$2.01$2.80Prior-year losses of $1.31 and $1.82
Adjusted EBITDA$112.3 million$196.6 millionUp from $51.0 million and $90.8 million
Adjusted EBITDA margin15.6%13.9%Up from 7.0% and 6.3%

Reported results benefited from lower product costs, favorable mix, cost-improvement initiatives, reduced distribution costs, lower interest expense, and a $65.0 million representation and warranty insurance gain. The six-month period also included a $4.7 million gain from debt repurchases. Discontinued operations contributed $11.0 million in the quarter and $22.7 million year to date, primarily from post-divestiture HHI and other indemnification adjustments.

Segment Performance

  • GPC: Sales declined 2.3% in the quarter and 1.3% year to date. Adjusted EBITDA increased to $62.3 million and $115.1 million, with margins of 21.5% and 20.3%, driven by improved mix, lower-cost inventory, and cost savings.
  • H&G: Sales increased 4.8% in the quarter and 3.6% year to date. Adjusted EBITDA increased to $29.2 million and $28.5 million, supported by seasonal volume, improved input costs, and manufacturing efficiencies.
  • HPC: Sales declined 4.0% in the quarter and 5.0% year to date, primarily from lower small-appliance volume. Adjusted EBITDA improved to $17.8 million and $44.5 million from prior-year losses or lower earnings, helped by pricing, SKU rationalization, cost improvements, and reduced excess inventory sales. Results included the $65.0 million insurance gain.

Cash Flow, Liquidity, and Capital Structure

  • Cash and cash equivalents were $745.7 million at March 31, 2024, compared with $753.9 million at September 30, 2023. Short-term investments were $500.0 million, down from $1.103 billion.
  • Six-month cash flow from continuing operations was $80.7 million, compared with $148.6 million in the prior-year period. Consolidated total operating cash flow, including discontinued operations, was negative $0.8 million.
  • Investing activities generated $544.1 million, largely reflecting $1.292 billion of short-term investment proceeds, partly offset by $700.0 million of purchases, $26.9 million of HHI purchase-price settlement, and $20.9 million of capital expenditures.
  • Financing activities used $553.8 million, including $177.9 million of debt repayment, $340.5 million of open-market share repurchases, and $26.8 million of dividends.
  • Total debt was approximately $1.383 billion gross, or $1.368 billion at fair value, including $1.374 billion of long-term debt net of issuance costs and $9.0 million of current debt. The Company repurchased $180.1 million of senior notes during the six months.
  • The $500.0 million revolving facility had $490.3 million of availability at March 31, 2024, net of letters of credit. Management stated that existing cash, operating cash flow, and credit availability should be sufficient for operating and capital needs for at least the next 12 months.
  • The Company was in compliance with its debt covenants and indentures at March 31, 2024. The quarterly dividend remained $0.42 per share.

Material Changes Versus the Prior Comparable Period

  • Revenue declined modestly, with lower GPC and HPC volumes partially offset by H&G growth. Organic sales decreased 1.6% in the quarter and 3.1% year to date.
  • Gross margin expanded substantially because of cost improvements, lower-cost inventory, favorable mix, and reduced excess-inventory activity.
  • The Company returned to profitability from continuing operations, aided by lower interest expense following debt reduction and higher interest income on cash investments.
  • Intangible-asset impairment declined to $39.0 million in the quarter and $43.0 million year to date from $67.0 million in the prior-year periods. The current-quarter charge primarily related to the Rejuvenate tradename following a lost distribution opportunity; the year-to-date amount also included a $4.0 million HPC tradename impairment.
  • Share repurchases totaled $423.7 million, or 5.8 million shares, during the six months. Weighted-average diluted shares declined to 30.4 million in the quarter from 41.0 million.
  • Operating cash flow weakened despite improved earnings, primarily because of working-capital changes, reduced receivables factoring, and higher tax payments.

Outlook, Commentary, Risks, and Unusual Items

  • Management expects operating cash flow, cash balances, and credit availability to fund operating and capital requirements for at least the next 12 months. No quantitative revenue or earnings guidance is provided in the filing text.
  • The Company continues initiatives to separate the HPC business, potentially through a spin, merger, or sale, while retaining GPC and H&G as a focused consumer-products company. Timing and transaction structure remain uncertain.
  • The new B+D trademark license agreement entered into in May 2024 has an initial term through December 31, 2027, with renewal rights subject to sales targets. Minimum annual royalties begin at $11.7 million and decline to $10.2 million during the initial term; the agreement also includes return-rate and promotional-spending requirements.
  • HPC product recalls remain a contingency. The CPSC required reissuance of a prior recall with full refunds, and recall liabilities were $6.2 million at March 31, 2024. Related indemnification receivables were $6.7 million.
  • Two large retail customers represented 33.5% of quarterly sales, 35.8% of six-month sales, and 43.7% of net trade receivables at March 31, 2024, creating customer-concentration risk.
  • Management continues to cite inflation, labor costs, transportation and commodity prices, foreign exchange, interest rates, geopolitical conflicts, supply-chain disruption, consumer demand, competition, seasonality, weather, cybersecurity, product liability, litigation, and regulatory risks.
  • The filing reports $4.9 million of environmental remediation liabilities and $2.6 million of product-liability reserves. Management does not expect currently pending legal matters or known contingencies to have a material adverse effect, but actual outcomes may differ.
  • The $65.0 million insurance gain, $39.0 million intangible impairment, $6.7 million HPC recall costs, $8.0 million of strategic and restructuring costs, and $4.7 million debt-repurchase gain materially affect comparability and adjusted metrics.

Important Facts for Investors to Verify

  • Whether gross-margin improvement and adjusted EBITDA gains persist after lower-cost inventory benefits, mix improvements, recall costs, and other exclusions normalize.
  • The sustainability of revenue and volume trends in HPC and GPC, and whether H&G seasonal demand meets retailer expectations.
  • The scope, cost, and timing of the HPC separation and any eventual transaction proceeds, tax effects, or stranded corporate costs.
  • Execution of the B+D license agreement, including royalty obligations, sales targets, return-rate requirements, and the concentration of B+D sales within HPC.
  • Remaining cash uses for debt reduction, share repurchases, dividends, strategic projects, and any potential asset-sale offer requirements under the debt agreements.
  • Future cash flow conversion, including the effects of receivables factoring suspension, working-capital seasonality, taxes, and discontinued-operation settlements.
  • Potential additional product-recall, litigation, environmental, indemnification, or warranty costs beyond recorded reserves.
  • Whether high customer concentration and reliance on third-party suppliers, distributors, and retailers affect future sales, liquidity, and margins.